Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Possible association of high-density lipoprotein cholesterol levels with trunk muscle deficits and decrease in energy expenditure in patients with or at risk for COPD: A pilot study.
Shirahata T, Sato H, Yogi S, Inoue K, Niitsu M, Miyazawa H, Akagami T, Soma M, Mio T, Nagata M, Nishida Y, Tanaka S, Katsukawa F, Nakamura H. Shirahata T, et al. Among authors: akagami t. Respir Investig. 2022 Sep;60(5):720-724. doi: 10.1016/j.resinv.2022.06.005. Epub 2022 Jul 9. Respir Investig. 2022. PMID: 35821189 Free article.
Improvement of sleep parameters by titration polysomnography could predict adherence to positive airway pressure therapy in obstructive sleep apnea.
Shirahata T, Uchida Y, Uchida T, Shinomiya S, Sato H, Yamazaki S, Yogi S, Masaki K, Akagami T, Soma M, Ohmura K, Miyashita T, Kanazawa M, Nagata M, Nakamura H. Shirahata T, et al. Among authors: akagami t. J Clin Sleep Med. 2023 Aug 1;19(8):1465-1473. doi: 10.5664/jcsm.10606. J Clin Sleep Med. 2023. PMID: 37082821
Non-exercise Activity Thermogenesis Correlated With Clinical Parameters in Patients With or At-Risk for Chronic Obstructive Pulmonary Disease (COPD): A Pilot Study.
Yogi S, Shirahata T, Sato H, Nishida Y, Inoue K, Niitsu M, Akagami T, Masaki K, Nagata M, Tanaka S, Katsukawa F, Nakamura H. Yogi S, et al. Among authors: akagami t. Cureus. 2024 Jan 26;16(1):e53019. doi: 10.7759/cureus.53019. eCollection 2024 Jan. Cureus. 2024. PMID: 38410298 Free PMC article.
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab.
Yamaguchi O, Kaira K, Shinomiya S, Mouri A, Hashimoto K, Shiono A, Miura Y, Akagami T, Imai H, Kobayashi K, Kagamu H. Yamaguchi O, et al. Among authors: akagami t. Thorac Cancer. 2021 Feb;12(3):304-313. doi: 10.1111/1759-7714.13725. Epub 2020 Nov 13. Thorac Cancer. 2021. PMID: 33185333 Free PMC article.
Clinical impact of post-progression survival on overall survival in patients receiving nivolumab monotherapy as a second-line treatment for advanced non-small cell lung cancer.
Imai H, Yamaguchi O, Mori K, Hashimoto K, Akagami T, Shinomiya S, Miura Y, Shiono A, Mouri A, Kaira K, Kobayashi K, Kagamu H. Imai H, et al. Among authors: akagami t. Thorac Cancer. 2021 Apr;12(8):1171-1179. doi: 10.1111/1759-7714.13886. Epub 2021 Feb 24. Thorac Cancer. 2021. PMID: 33626218 Free PMC article.
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.
Miura Y, Mouri A, Kaira K, Yamaguchi O, Shiono A, Hashimoto K, Nishihara F, Shinomiya S, Akagami T, Murayama Y, Abe T, Noda SE, Kato S, Kobayashi K, Kagamu H. Miura Y, et al. Among authors: akagami t. Thorac Cancer. 2020 May;11(5):1280-1287. doi: 10.1111/1759-7714.13394. Epub 2020 Mar 11. Thorac Cancer. 2020. PMID: 32160383 Free PMC article.
31 results